These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

708 related items for PubMed ID: 17996657

  • 1. Self-reported efficacy and tolerability of ramelteon 8 mg in older adults experiencing severe sleep-onset difficulty.
    Mini LJ, Wang-Weigand S, Zhang J.
    Am J Geriatr Pharmacother; 2007 Sep; 5(3):177-84. PubMed ID: 17996657
    [Abstract] [Full Text] [Related]

  • 2. Effects of ramelteon on patient-reported sleep latency in older adults with chronic insomnia.
    Roth T, Seiden D, Sainati S, Wang-Weigand S, Zhang J, Zee P.
    Sleep Med; 2006 Jun; 7(4):312-8. PubMed ID: 16709464
    [Abstract] [Full Text] [Related]

  • 3. Ramelteon for the treatment of insomnia.
    Borja NL, Daniel KL.
    Clin Ther; 2006 Oct; 28(10):1540-55. PubMed ID: 17157111
    [Abstract] [Full Text] [Related]

  • 4. Efficacy and safety of ramelteon in Japanese adults with chronic insomnia: a randomized, double-blind, placebo-controlled study.
    Uchimura N, Ogawa A, Hamamura M, Hashimoto T, Nagata H, Uchiyama M.
    Expert Rev Neurother; 2011 Feb; 11(2):215-24. PubMed ID: 21306209
    [Abstract] [Full Text] [Related]

  • 5. Use of a post-sleep questionnaire-interactive voice response system (PSQ-IVRS) to evaluate the subjective sleep effects of ramelteon in adults with chronic insomnia.
    Wang-Weigand S, Watissée M, Roth T.
    Sleep Med; 2011 Oct; 12(9):920-3. PubMed ID: 21925941
    [Abstract] [Full Text] [Related]

  • 6. Effects of long-term exposure to ramelteon, a melatonin receptor agonist, on endocrine function in adults with chronic insomnia.
    Richardson G, Wang-Weigand S.
    Hum Psychopharmacol; 2009 Mar; 24(2):103-11. PubMed ID: 19090503
    [Abstract] [Full Text] [Related]

  • 7. Ramelteon: a novel approach in the treatment of insomnia.
    Reynoldson JN, Elliott E, Nelson LA.
    Ann Pharmacother; 2008 Sep; 42(9):1262-71. PubMed ID: 18648020
    [Abstract] [Full Text] [Related]

  • 8. Efficacy and tolerability of modified-release indiplon in elderly patients with chronic insomnia: results of a 2-week double-blind, placebo-controlled trial.
    Lydiard RB, Lankford DA, Seiden DJ, Landin R, Farber R, Walsh JK.
    J Clin Sleep Med; 2006 Jul 15; 2(3):309-15. PubMed ID: 17561543
    [Abstract] [Full Text] [Related]

  • 9. The effects of ramelteon in a first-night model of transient insomnia.
    Zammit G, Schwartz H, Roth T, Wang-Weigand S, Sainati S, Zhang J.
    Sleep Med; 2009 Jan 15; 10(1):55-9. PubMed ID: 18691937
    [Abstract] [Full Text] [Related]

  • 10. An efficacy, safety, and dose-response study of Ramelteon in patients with chronic primary insomnia.
    Erman M, Seiden D, Zammit G, Sainati S, Zhang J.
    Sleep Med; 2006 Jan 15; 7(1):17-24. PubMed ID: 16309958
    [Abstract] [Full Text] [Related]

  • 11. Ramelteon 8 mg/d versus placebo in patients with chronic insomnia: post hoc analysis of a 5-week trial using 50% or greater reduction in latency to persistent sleep as a measure of treatment effect.
    Mini L, Wang-Weigand S, Zhang J.
    Clin Ther; 2008 Jul 15; 30(7):1316-23. PubMed ID: 18691991
    [Abstract] [Full Text] [Related]

  • 12. Efficacy and tolerability of indiplon in older adults with primary insomnia.
    Walsh JK, Moscovitch A, Burke J, Farber R, Roth T.
    Sleep Med; 2007 Nov 15; 8(7-8):753-9. PubMed ID: 17825616
    [Abstract] [Full Text] [Related]

  • 13. Evaluation of the efficacy and safety of ramelteon in subjects with chronic insomnia.
    Zammit G, Erman M, Wang-Weigand S, Sainati S, Zhang J, Roth T.
    J Clin Sleep Med; 2007 Aug 15; 3(5):495-504. PubMed ID: 17803013
    [Abstract] [Full Text] [Related]

  • 14. Efficacy and safety of zolpidem-MR: a double-blind, placebo-controlled study in adults with primary insomnia.
    Roth T, Soubrane C, Titeux L, Walsh JK, Zoladult Study Group.
    Sleep Med; 2006 Aug 15; 7(5):397-406. PubMed ID: 16815744
    [Abstract] [Full Text] [Related]

  • 15. Effects of armodafinil in the treatment of residual excessive sleepiness associated with obstructive sleep apnea/hypopnea syndrome: a 12-week, multicenter, double-blind, randomized, placebo-controlled study in nCPAP-adherent adults.
    Roth T, White D, Schmidt-Nowara W, Wesnes KA, Niebler G, Arora S, Black J.
    Clin Ther; 2006 May 15; 28(5):689-706. PubMed ID: 16861091
    [Abstract] [Full Text] [Related]

  • 16. Effect of zolpidem on sleep in women with perimenopausal and postmenopausal insomnia: a 4-week, randomized, multicenter, double-blind, placebo-controlled study.
    Dorsey CM, Lee KA, Scharf MB.
    Clin Ther; 2004 Oct 15; 26(10):1578-86. PubMed ID: 15598474
    [Abstract] [Full Text] [Related]

  • 17. A polysomnography study of eszopiclone in elderly patients with insomnia.
    McCall WV, Erman M, Krystal AD, Rosenberg R, Scharf M, Zammit GK, Wessel T.
    Curr Med Res Opin; 2006 Sep 15; 22(9):1633-42. PubMed ID: 16968566
    [Abstract] [Full Text] [Related]

  • 18. Fentanyl buccal tablet for the relief of breakthrough pain in opioid-tolerant adult patients with chronic neuropathic pain: a multicenter, randomized, double-blind, placebo-controlled study.
    Simpson DM, Messina J, Xie F, Hale M.
    Clin Ther; 2007 Apr 15; 29(4):588-601. PubMed ID: 17617282
    [Abstract] [Full Text] [Related]

  • 19. A randomized, placebo-controlled study of adjunctive ramelteon in ambulatory bipolar I disorder with manic symptoms and sleep disturbance.
    McElroy SL, Winstanley EL, Martens B, Patel NC, Mori N, Moeller D, McCoy J, Keck PE.
    Int Clin Psychopharmacol; 2011 Jan 15; 26(1):48-53. PubMed ID: 20861739
    [Abstract] [Full Text] [Related]

  • 20. Efficacy and clinical safety of ramelteon: an evidence-based review.
    Sateia MJ, Kirby-Long P, Taylor JL.
    Sleep Med Rev; 2008 Aug 15; 12(4):319-32. PubMed ID: 18603221
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 36.